Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment with maximal dexamethasone dose

Synthetic glucocorticoids (GCs) are widely used in the variety of dosages for treatment of premature infants with chronic lung disease, respiratory distress syndrome, allergies, asthma, and other inflammatory and autoimmune conditions. Yet, adverse effects such as glucocorticoid-induced osteoporosis...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Exp Biol Med (Maywood)
Asıl Yazarlar: Dobrowolski, Piotr, Tomaszewska, Ewa, Muszyński, Siemowit, Blicharski, Tomasz, Pierzynowski, Stefan G
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2017
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363691/
https://ncbi.nlm.nih.gov/pubmed/28178857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217693322
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller